Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04646226 · ClinicalTrials.gov registry record · NA
The Arteriovenous Vascular (AV) ACCESS Trial
A NA study of End-Stage Kidney Disease and Hemodialysis Complication, sponsored by Wake Forest University Health Sciences.
- Active
- Registry status
- NA
- Development phase
- 103
- Enrollment target
- 7
- Study locations
NCT04646226: Active NA study of End-Stage Kidney Disease and Hemodialysis Complication, sponsored by Wake Forest University Health Sciences.
NCT04646226 is a NA study of End-Stage Kidney Disease and Hemodialysis Complication that is active but no longer recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 103 participants, below the 461-participant average among 20 other End-Stage Kidney Disease trials with a reported enrollment target (78% lower). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04646226, a NA study of End-Stage Kidney Disease and Hemodialysis Complication, is active but no longer recruiting, sponsored by Wake Forest University Health Sciences.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
- 7
- Study locations
Study Summary
This study is to prospectively compare the effectiveness and safety of the two types of arteriovenous access placement (fistula or graft) in older adults with end stage kidney disease and multiple chronic conditions
Primary Outcome
Determine the effects of arteriovenous (AV) fistula vs. AV graft vascular access strategy on the rate of catheter-free dialysis days
Conditions Studied
Interventions
- DEVICE AV graft
- PROCEDURE surgical intervention for creation of a fistula
Study Locations (7)
Alabama
- University of Alabama at Birmingham School of Medicine - Birmingham
California
- UCLA - Los Angeles
Maryland
- Johns Hopkins School of Medicine - Baltimore
North Carolina
- Atrium Wake Forest Baptist Medical Center - Winston-Salem
South Carolina
- Prisma Health Upstate - Greenville
Tennessee
- University of Tennessee Medical Center at Knoxville - Knoxville
Wisconsin
- University of Wisconsin School of Medicine and Public Health - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2022-08-18 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
What the registry record for NCT04646226 still lists
NCT04646226 is an interventional study that assigns participants to a tested intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap, below the 461-participant average among 20 other End-Stage Kidney Disease trials with a reported enrollment target (78% lower).
The record links to 2 conditions, with End-Stage Kidney Disease appearing as the primary indexed condition, and to 2 interventions - of which AV graft is the first listed.
NCT04646226 lists 7 locations in 7 states (Alabama, California, Maryland).
Frequently Asked Questions
What is clinical trial NCT04646226 about?
NCT04646226 is a clinical study titled "The Arteriovenous Vascular (AV) ACCESS Trial". This study is to prospectively compare the effectiveness and safety of the two types of arteriovenous access placement (fistula or graft) in older adults with end stage kidney disease and multiple chronic conditions
What is the current status of trial NCT04646226?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 103 participants. The study started on 2022-08-18. Estimated completion is 2027-08-31.
What conditions does trial NCT04646226 study?
This clinical trial studies the following conditions: End-Stage Kidney Disease, Hemodialysis Complication.
What interventions are being tested in trial NCT04646226?
The interventions under investigation include: AV graft (DEVICE), surgical intervention for creation of a fistula (PROCEDURE).
Who is sponsoring clinical trial NCT04646226?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04646226 being conducted?
This trial has 7 study locations across Alabama, California, Maryland, North Carolina, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for End-Stage Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04646226's enrollment target sits among peer trials
103 9th of 20 higher than 11 of 20 other End-Stage Kidney Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other End-Stage Kidney Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Incremental Hemodialysis: The TwoPlus Trial
RECRUITING · NA
-
Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision
RECRUITING · NA
-
Symptom Monitoring in Hemodialysis
RECRUITING · NA
-
Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants
RECRUITING · NA
-
Pain Reduction Using NEurostimulation Study
RECRUITING · NA
-
Staged Kidney Transplantation During Combined Heart/Kidney Transplantation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI